PDCD1 and neoplasm: For a high efficacy and clinical response to ICI therapy, mapping of PD-1 expression on tumor-infiltrating immune cells and scoring the tumor infiltration but also PD-1 expression on tumor cells is necessary before a treatment strategy decision is made.